Which statement regarding the drug SR 141716A is false?
A) It decreases appetite and may serve as an anti-obesity agent.
B) It causes hyperalgesia.
C) It reduces depressive-like behaviors.
D) It acts as a cannabinoid antagonist.

Question

Quizplus · Accepted Answer

SR 141716A, also known as Rimonabant, is a cannabinoid antagonist that has been shown to decrease appetite and may serve as an anti-obesity agent. It can cause hyperalgesia by blocking the cannabinoid receptors, which are involved in pain modulation. However, it does not reduce depressive-like behaviors; in fact, it has been associated with increased risk of depression and anxiety, leading to its withdrawal from the market in some countries.

Which Statement Regarding the Drug SR 141716A Is False